These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9607021)

  • 1. Protection against measles virus-induced encephalitis by antibodies from mice immunized intranasally with a synthetic peptide immunogen.
    Hathaway LJ; Obeid OE; Steward MW
    Vaccine; 1998; 16(2-3):135-41. PubMed ID: 9607021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection against morbillivirus-induced encephalitis by immunization with a rationally designed synthetic peptide vaccine containing B- and T-cell epitopes from the fusion protein of measles virus.
    Obeid OE; Partidos CD; Howard CR; Steward MW
    J Virol; 1995 Mar; 69(3):1420-8. PubMed ID: 7531779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological analysis of the protective responses to the chimeric synthetic peptide representing T- and B-cell epitopes from the fusion protein of measles virus.
    Obeid OE; Stanley CM; Steward MW
    Virus Res; 1996 Jun; 42(1-2):173-80. PubMed ID: 8806185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against measles virus-induced encephalitis by anti-mimotope antibodies: the role of antibody affinity.
    Olszewska W; Obeid OE; Steward MW
    Virology; 2000 Jun; 272(1):98-105. PubMed ID: 10873752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A hemagglutinin-derived peptide-vaccine ignored by virus-neutralizing passive antibodies, protects against murine measles encephalitis.
    El Kasmi KC; Theisen D; Brons NH; Ammerlaan W; Klingele M; Truong AT; Muller CP
    Vaccine; 1999 May; 17(19):2436-45. PubMed ID: 10392626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of systemic immune responses to measles virus synthetic peptides administered intranasally.
    Hathaway LJ; Partidos CD; Vohra P; Steward MW
    Vaccine; 1995 Nov; 13(16):1495-500. PubMed ID: 8578832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mimotope from a solid-phase peptide library induces a measles virus-neutralizing and protective antibody response.
    Steward MW; Stanley CM; Obeid OE
    J Virol; 1995 Dec; 69(12):7668-73. PubMed ID: 7494275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Priming of measles virus-specific CTL responses after immunization with a CTL epitope linked to a fusogenic peptide.
    Partidos CD; Vohra P; Steward MW
    Virology; 1996 Jan; 215(1):107-10. PubMed ID: 8553582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fine specificity of the antibody response to a synthetic peptide from the fusion protein and protection against measles virus-induced encephalitis in a mouse model.
    Partidos CD; Ripley J; Delmas A; Obeid OE; Denbury A; Steward MW
    J Gen Virol; 1997 Dec; 78 ( Pt 12)():3227-32. PubMed ID: 9400973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of an immunodominant neutralizing and protective epitope from measles virus fusion protein by using human sera from acute infection.
    Atabani SF; Obeid OE; Chargelegue D; Aaby P; Whittle H; Steward MW
    J Virol; 1997 Oct; 71(10):7240-5. PubMed ID: 9311797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The molecular basis of the antigenic cross-reactivity between measles and cowpea mosaic viruses.
    Olszewska W; Steward MW
    Virology; 2003 May; 310(1):183-9. PubMed ID: 12788642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral immunization with recombinant Yersinia enterocolitica expressing a measles virus CD4 T cell epitope protects against measles virus-induced encephalitis.
    Gundel I; Weidinger G; Ter Meulen V; Heesemann J; Rüssmann H; Niewiesk S
    J Gen Virol; 2003 Apr; 84(Pt 4):775-779. PubMed ID: 12655077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholera toxin B stimulates systemic neutralizing antibodies after intranasal co-immunization with measles virus.
    Muller CP; Beauverger P; Schneider F; Jung G; Brons NH
    J Gen Virol; 1995 Jun; 76 ( Pt 6)():1371-80. PubMed ID: 7782766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal immunization with inactivated tick-borne encephalitis virus and the antigenic peptide 89-119 protects mice against intraperitoneal challenge.
    Goncharova E; Ryzhikov E; Poryvaev V; Bulychev L; Karpyshev N; Maksyutov A; Ryzhikov AB
    Int J Med Microbiol; 2006 May; 296 Suppl 40():195-201. PubMed ID: 16545605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection against measles virus encephalitis by monoclonal antibodies binding to a cystine loop domain of the H protein mimicked by peptides which are not recognized by maternal antibodies.
    Ziegler D; Fournier P; Berbers GA; Steuer H; Wiesmüller KH; Fleckenstein B; Schneider F; Jung G; King CC; Muller CP
    J Gen Virol; 1996 Oct; 77 ( Pt 10)():2479-89. PubMed ID: 8887481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of measles virus-specific cytotoxic T-cell responses after intranasal immunization with synthetic peptides.
    Partidos CD; Vohra P; Steward MW
    Immunology; 1996 Feb; 87(2):179-85. PubMed ID: 8698377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of an internal permissive site in the cholera toxin B-subunit and insertion of epitopes from human immunodeficiency virus-1, hepatitis B virus and enterotoxigenic Escherichia coli.
    Bckström M; Holmgren J; Schödel F; Lebens M
    Gene; 1995 Nov; 165(2):163-71. PubMed ID: 8522171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal immunization with SIV virus-like particles (VLPs) elicits systemic and mucosal immunity.
    Yao Q; Vuong V; Li M; Compans RW
    Vaccine; 2002 Jun; 20(19-20):2537-45. PubMed ID: 12057610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection against lethal measles virus infection in mice by immune-stimulating complexes containing the hemagglutinin or fusion protein.
    Varsanyi TM; Morein B; Löve A; Norrby E
    J Virol; 1987 Dec; 61(12):3896-901. PubMed ID: 2960833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epitope polarity and adjuvants influence the fine specificity of the humoral response against Semliki Forest virus specific peptide vaccines.
    Fernández IM; Harmsen M; Benaissa-Trouw BJ; Stuij I; Puyk W; Meloen RH; Snippe H; Kraaijeveld CA
    Vaccine; 1998 Oct; 16(16):1531-6. PubMed ID: 9711800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.